Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
31 studies found for:    lectins
Show Display Options
Rank Status Study
1 Withdrawn Recombinant Human Mannose-Binding Lectin (MBL) in Treating Young Patients With MBL Deficiency and Fever and Neutropenia
Conditions: Fever, Sweats, and Hot Flashes;   Infection;   Leukemia;   Lymphoma;   Myelodysplastic Syndromes;   Neutropenia;   Unspecified Childhood Solid Tumor, Protocol Specific
Intervention: Biological: recombinant human mannose-binding lectin
2 Active, not recruiting The Complement Lectin Pathway After Cardiac Arrest
Conditions: Out-of-Hospital Cardiac Arrest;   Post Cardiac Arrest Syndrome
Intervention: Other: Targeted temperature management (33 degree Celsius)
3 Completed Study on Mannan Binding Lectin (MBL) Substitution in MBL-Deficient Children With Chemotherapy-Induced Neutropenia
Conditions: MBL-Deficient;   Neutropenia
Interventions: Drug: Mannan Binding Lectin (MBL);   Drug: Mannan Binding Lectin
4 Completed The Effect of Weight Loss on Serum Mannose-Binding Lectin(MBL) Levels
Conditions: Obesity;   Weight Loss
Intervention: Other: Weight loss
5 Completed Mistletoe Lectin in Treating Patients With Refractory Advanced Solid Tumors
Condition: Unspecified Adult Solid Tumor, Protocol Specific
Intervention: Dietary Supplement: mistletoe extract
6 Completed Mistletoe Lectin in Treating Patients With Advanced Solid Tumors That Have Not Responded to Previous Therapy
Condition: Unspecified Adult Solid Tumor, Protocol Specific
Intervention: Dietary Supplement: mistletoe extract
7 Completed Genetic Polymorphisms of Mannan-binding Lectin (MBL)and Serum Levels of MBL in Patients With Endometriosis
Condition: Endometriosis
Intervention:
8 Completed Association Between Deficiency of MBL (Mannose-Binding Lectin) and Polymorphisms in MBL2 Gene to Urinary Tract Infection
Condition: Recurrent Urinary Tract Infections
Intervention:
9 Terminated A Multicenter Study Evaluating the Safety and Tolerability of Intravenous rhMBL in Liver Transplant Recipients.
Condition: Liver Transplantation
Intervention: Drug: Intravenous Recombinant Human Mannose-Binding Lectin (rhMBL)
10 Withdrawn A Study of Safety, Tolerability, and Pk of rhMBL in Pediatric Hematology/Oncology Pts With Fever and Neutropenia
Conditions: Cancer;   Hematologic Diseases;   Fever;   Neutropenia
Intervention: Drug: Intravenous recombinant human mannose binding lectin
11 Completed Study of the Level of a Protein Which Could Predict the Development of a Fungal Infection in Patients With Acute Leukemia
Conditions: Acute Leukemia;   Invasive Fungal Infection
Intervention: Biological: blood sample
12 Recruiting Innate Immunity Gene Polymorphisms and Yeast Colonization
Condition: Critical Illness
Intervention:
13 Completed Intravenous rhMBL in Patients With Multiple Myeloma Receiving Chemotherapy Followed by Stem Cell Transplant
Condition: Multiple Myeloma
Intervention: Drug: Intravenous Recombinant Human Mannose-Binding Lectin (rhMBL)
14 Recruiting Immunological Interaction Between the Host and Candida Albicans Biofilm
Condition: Candidiasis
Intervention:
15 Recruiting Lung and Systemic Inflammation in the Critically Ill Patient
Conditions: Acute Respiratory Distress Syndrome (ARDS);   Systemic Inflammatory Response Syndrome (SIRS);   Sepsis
Intervention:
16 Recruiting Preventing Fucose-dependent Binding of Aspergillus and Pseudomonas to Lung Mucin
Condition: Cystic Fibrosis
Intervention:
17 Active, not recruiting Immune Profile and Complication Risk in Type 2 Diabetes
Condition: Diabetes Mellitus, Type 2
Intervention:
18 Terminated
Has Results
Metabolic Factors of Outcomes From Gastric Bypass Surgery
Condition: Obesity
Intervention:
19 Completed Determination of Genetic Polymorphisms in Chronic Chagas Cardiomyopathy
Condition: Chagas Disease
Intervention: Genetic: Gathering of samples of genetic material
20 Recruiting A Phase I Study Priming With an Inactivated A/H7N9 Influenza Virus Vaccine With or Without MF59 Adjuvant Followed by Live Attenuated A/H7N9 Influenza Virus Vaccine
Condition: Avian Influenza
Interventions: Drug: MF59;   Biological: Influenza Virus Vaccine, Live Attenuated H7N9 Anhui 2013/AA ca;   Biological: Influenza Virus Vaccine, Monovalent A/H7N9 A/Shanghai/2/2013

   Previous Page Studies Shown (1-20) Next Page (21-31) Show next page of results    Last Page
Indicates status has not been verified in more than two years